These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37549741)

  • 21. Biological markers of fetal lead exposure at each stage of pregnancy.
    Lamadrid-Figueroa H; Téllez-Rojo MM; Hernández-Cadena L; Mercado-García A; Smith D; Solano-González M; Hernández-Avila M; Hu H
    J Toxicol Environ Health A; 2006 Oct; 69(19):1781-96. PubMed ID: 16905508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of Fetal Darunavir Exposure by Integrating Human Ex-Vivo Placental Transfer and Physiologically Based Pharmacokinetic Modeling.
    Schalkwijk S; Buaben AO; Freriksen JJM; Colbers AP; Burger DM; Greupink R; Russel FGM
    Clin Pharmacokinet; 2018 Jun; 57(6):705-716. PubMed ID: 28744795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing the impacts on fetal dosimetry of the modelling of the placental transfers of xenobiotics in a pregnancy physiologically based pharmacokinetic model.
    Codaccioni M; Brochot C
    Toxicol Appl Pharmacol; 2020 Dec; 409():115318. PubMed ID: 33160985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physiologically based pharmacokinetic modeling to predict maternal pharmacokinetics and fetal carbamazepine exposure during pregnancy.
    Chen Y; Ke M; Fang W; Jiang Y; Lin R; Wu W; Huang P; Lin C
    Eur J Pharm Sci; 2024 Mar; 194():106707. PubMed ID: 38244810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Placental Transfer and Tissue Distribution of
    Personne S; Brochot C; Marcelo P; Corona A; Desmots S; Robidel F; Lecomte A; Bach V; Zeman F
    Front Pediatr; 2021; 9():730383. PubMed ID: 34631627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimation of Fetal-to-Maternal Unbound Steady-State Plasma Concentration Ratio of P-Glycoprotein and/or Breast Cancer Resistance Protein Substrate Drugs Using a Maternal-Fetal Physiologically Based Pharmacokinetic Model.
    Peng J; Ladumor MK; Unadkat JD
    Drug Metab Dispos; 2022 May; 50(5):613-623. PubMed ID: 35149540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting Human Fetal Drug Exposure Through Maternal-Fetal PBPK Modeling and In Vitro or Ex Vivo Studies.
    Balhara A; Kumar AR; Unadkat JD
    J Clin Pharmacol; 2022 Sep; 62 Suppl 1(Suppl 1):S94-S114. PubMed ID: 36106781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationships between trace element concentrations in chorionic tissue of placenta and umbilical cord tissue: potential use as indicators for prenatal exposure.
    Sakamoto M; Yasutake A; Domingo JL; Chan HM; Kubota M; Murata K
    Environ Int; 2013 Oct; 60():106-11. PubMed ID: 24028800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimization of the betamethasone and dexamethasone dosing regimen during pregnancy: a combined placenta perfusion and pregnancy physiologically based pharmacokinetic modeling approach.
    Van Der Heijden JEM; Van Hove H; Van Elst NM; Van Den Broek P; Van Drongelen J; Scheepers HCJ; De Wildt SN; Greupink R
    Am J Obstet Gynecol; 2024 May; ():. PubMed ID: 38763343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Revisiting mobilisation of skeletal lead during pregnancy based on monthly sampling and cord/maternal blood lead relationships confirm placental transfer of lead.
    Gulson B; Mizon K; Korsch M; Taylor A
    Arch Toxicol; 2016 Apr; 90(4):805-16. PubMed ID: 25877328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of human fetal pharmacokinetics using ex vivo human placenta perfusion studies and physiologically based models.
    De Sousa Mendes M; Hirt D; Vinot C; Valade E; Lui G; Pressiat C; Bouazza N; Foissac F; Blanche S; Lê MP; Peytavin G; Treluyer JM; Urien S; Benaboud S
    Br J Clin Pharmacol; 2016 Apr; 81(4):646-57. PubMed ID: 26518984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurodevelopment for the first three years following prenatal mobile phone use, radio frequency radiation and lead exposure.
    Choi KH; Ha M; Ha EH; Park H; Kim Y; Hong YC; Lee AK; Hwa Kwon J; Choi HD; Kim N; Kim S; Park C
    Environ Res; 2017 Jul; 156():810-817. PubMed ID: 28511138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prenatal lead and cadmium co-exposure and infant neurodevelopment at 6 months of age: the Mothers and Children's Environmental Health (MOCEH) study.
    Kim Y; Ha EH; Park H; Ha M; Kim Y; Hong YC; Kim EJ; Kim BN
    Neurotoxicology; 2013 Mar; 35():15-22. PubMed ID: 23220728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maternal and fetal exposure to cadmium, lead, manganese and mercury: The MIREC study.
    Arbuckle TE; Liang CL; Morisset AS; Fisher M; Weiler H; Cirtiu CM; Legrand M; Davis K; Ettinger AS; Fraser WD;
    Chemosphere; 2016 Nov; 163():270-282. PubMed ID: 27540762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimating fetal exposure to the P-gp substrates, corticosteroids, by PBPK modeling to inform prevention of neonatal respiratory distress syndrome.
    Anoshchenko O; Milad MA; Unadkat JD
    CPT Pharmacometrics Syst Pharmacol; 2021 Sep; 10(9):1057-1070. PubMed ID: 34273255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A review of pregnancy-induced changes in opioid pharmacokinetics, placental transfer, and fetal exposure: Towards fetomaternal physiologically-based pharmacokinetic modeling to improve the treatment of neonatal opioid withdrawal syndrome.
    van Hoogdalem MW; Wexelblatt SL; Akinbi HT; Vinks AA; Mizuno T
    Pharmacol Ther; 2022 Jun; 234():108045. PubMed ID: 34813863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating placental transfer and tissue concentrations of manganese in the pregnant rat and fetuses after inhalation exposures with a PBPK model.
    Yoon M; Nong A; Clewell HJ; Taylor MD; Dorman DC; Andersen ME
    Toxicol Sci; 2009 Nov; 112(1):44-58. PubMed ID: 19726578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of human prenatal exposure to bisphenol A and bisphenol A glucuronide from an ovine semi-physiological toxicokinetic model.
    Gauderat G; Picard-Hagen N; Toutain PL; Servien R; Viguié C; Puel S; Lacroix MZ; Corbel T; Bousquet-Melou A; Gayrard V
    Sci Rep; 2017 Nov; 7(1):15330. PubMed ID: 29127374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maternal bone lead as an independent risk factor for fetal neurotoxicity: a prospective study.
    Gomaa A; Hu H; Bellinger D; Schwartz J; Tsaih SW; Gonzalez-Cossio T; Schnaas L; Peterson K; Aro A; Hernandez-Avila M
    Pediatrics; 2002 Jul; 110(1 Pt 1):110-8. PubMed ID: 12093955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prenatal exposure to PFOS and PFOA in a pregnant women cohort of Catalonia, Spain.
    Rovira J; Martínez MÁ; Sharma RP; Espuis T; Nadal M; Kumar V; Costopoulou D; Vassiliadou I; Leondiadis L; Domingo JL; Schuhmacher M
    Environ Res; 2019 Aug; 175():384-392. PubMed ID: 31154228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.